Clinical Trial Update: Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Multiple Oral Bedtime Doses of ORMD-0801 in Adult Patients With Type 2 Diabetes Mellitus (T2DM) [Phase 2]

View source ↗

Summary

Phase 2 study assessing safety, pharmacokinetics, and pharmacodynamics of multiple oral bedtime doses of ORMD-0801 in adults with Type 2 diabetes mellitus. Resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• ORMD-0801

Snippet

Sponsor: Oramed, Ltd. | Conditions: Diabetes Mellitus Type 2 | Phase 2 | Status: COMPLETED | Results posted: 2014-10-24